(For treatment side effects and complications only)
Preparations are being made by government for the
exit of the UK from the EU. This is happening at a national level and by the
Plans and contingencies are in place and we are very
carefully monitoring the position. Our workforce team is managing the situation
with any employees impacted and there is currently no impact on recruitment.
We have confidence in our supply chain’s ability to
source medicines and national plans are in place for the provision of essential
treatment components such as radioisotopes.
We continue to follow the government advice provided
and, as things develop week by week, will continue to review the position in
light of any new information becoming available.